. . . . . . . "[This trial demonstrated that overexpression of type I IFN signature in SLE is at least partly driven by IFN?, and exploratory analyses suggest that IFN? inhibition may be associated with clinical benefit in SLE.Trial registration number NCT00299819.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:35+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .